Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gianluigi Cabiddu"'
Autor:
Patrizia Nadia Hanieh, Sara Consalvi, Jacopo Forte, Gianluigi Cabiddu, Alessandro De Logu, Giovanna Poce, Federica Rinaldi, Mariangela Biava, Maria Carafa, Carlotta Marianecci
Publikováno v:
Pharmaceutics, Vol 14, Iss 3, p 610 (2022)
Tuberculosis remains one of the world’s deadliest infectious diseases, accounting for nearly 1.3 million deaths every year. Tuberculosis treatment is challenging because of the toxicity, decreased bioavailability at the target site of the conventio
Externí odkaz:
https://doaj.org/article/cb217c00a4bc4988a3a3b7f1c68d2b85
Autor:
Daniele Zampieri, Sara Fortuna, Maurizio Romano, Alessandro De Logu, Gianluigi Cabiddu, Adriana Sanna, Maria Grazia Mamolo
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 23; Pages: 15295
To extend our screening for novel antimycobacterial molecules, we have designed, synthesized, and biologically evaluated a library of 14 new hydrazide derivatives containing 1,3,4-oxadiazole core. A variety of mycobacterial strains, including some dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a587915162d229d6829543b81606f19
https://doi.org/10.3390/ijms232315295
https://doi.org/10.3390/ijms232315295
Autor:
Alessandra Olianas, Gianluigi Cabiddu, Pauline Maes, Martine Morzel, Franck Hyvrier, Francis Canon, Hélène Brignot, Barbara Manconi, Tiziana Cabras
Publikováno v:
Journal of Proteomics
Journal of Proteomics, Elsevier, 2020, 222, pp.103797. ⟨10.1016/j.jprot.2020.103797⟩
Journal of Proteomics, Elsevier, 2020, 222, pp.103797. ⟨10.1016/j.jprot.2020.103797⟩
The oral mucosal pellicle is a thin lubricating layer generated by the binding of saliva proteins on epithelial oral cells. The protein composition of this biological structure has been to date studied by targeted analyses of specific salivary protei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53504977c6802c807c0e9c1a55f1e361
https://doi.org/10.1016/j.jprot.2020.103797
https://doi.org/10.1016/j.jprot.2020.103797
Autor:
Riccardo Martini, Elisa Rita Ceresola, Bruno Botta, Massimo Clementi, Enzo Tramontano, Andrea Calcaterra, Cristina Tintori, Frauke Christ, Gianluigi Cabiddu, Filippo Canducci, Francesca Esposito, Valentina Iovine, Maurizio Botta, Roberto Ferrarese, Zeger Debyser, Angela Corona
HIV-1 integrase (IN) active site inhibitors are the latest class of drugs approved for HIV treatment. The selection of IN strand-transfer drug-resistant HIV strains in patients supports the development of new agents that are active as allosteric IN i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::660f05a91bd043637536fa795e186aba
http://hdl.handle.net/11383/2057939
http://hdl.handle.net/11383/2057939
